| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000002690 |
| Receipt No. | R000003285 |
| Official scientific title of the study | Evaluation of pulmonary nodules by using CT perfusion technique |
| Date of disclosure of the study information | 2009/10/30 |
| Last modified on | 2016/04/29 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Evaluation of pulmonary nodules by using CT perfusion technique | |
| Title of the study (Brief title) | Evaluation of pulmonary nodules by using CT perfusion technique | |
| Region |
|
|
| Condition | |||
| Condition | pulmonary nodular lesion | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Differentiating benign or malignant lesion by CT perfusion study using dynamic contrast enhancement for nodular lesions smaller than 3 centimeters. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Correlation between perfusion dynamics of nodular lesion and histopathologic diagnosis |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | CT perfusion study by dynamic contrast enhancement | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who have pulmonary nodular lesion smaller than 3 centimeters | |||
| Key exclusion criteria | Patient younger than 40 years old
Contraindication of contrast agent such as allergy, severe renal dysfunction, etc. |
|||
| Target sample size | 60 | |||
| Research contact person | |
| Name of lead principal investigator | Fumikazu Sakai |
| Organization | Saitama Medical University International Medical Center |
| Division name | Department of Diagnostic Radiology |
| Address | 1397-1, Yamane, Hidaka, Saitama |
| TEL | 042-984-4520 |
| fmksakai@saitama-med.ac.jp | |
| Public contact | |
| Name of contact person | Fumikazu Sakai |
| Organization | Saitama Medical University International Medical Center |
| Division name | Department of Diagnostic Radiology |
| Address | 1397-1, Yamane, Hidaka, Saitama |
| TEL | 042-984-4520 |
| Homepage URL | |
| fmksakai@saitama-med.ac.jp | |
| Sponsor | |
| Institute | Department of Diagnostic Radiology, Saitama Medical University International Medical Center |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | nothing |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 埼玉医科大学国際医療センター(埼玉県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000003285 |